AusPAR: Atezolizumab

Australian Public Assessment Report

AusPAR

AusPAR: Atezolizumab [PDF, 954.51 KB]

AusPAR: Atezolizumab [Word, 2.38 MB]

Attachment: Product Information Atezolizumab [PDF, 822.43 KB]

Attachment: Product Information Atezolizumab [Word, 1.33 MB]

Device/Product Name

Tecentriq

Active ingredients

Atezolizumab

AusPAR Date

4 June 2020

Published

18 June 2020

Submission Number

PM-2019-00505-1-4

Submission Type

Extension of indications

Decision

Approved